Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    " January 13, 2014":" February 12, 2014"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Recruiting Optimizing Clinical Outcomes in HIV-Infected Adults & Children
Conditions: Tuberculosis Diagnosis;   HIV
Intervention: Other: Xpert MTB/RIF Tuberculosis diagnostic tool
22 Recruiting Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3
Condition: HIV-1 Infection
Interventions: Device: Xpert MTB/RIF®, Determine TB LAM, Chest X-ray;   Drug: ART (Atripla, Truvada, Efavirenz, Combivir);   Drug: Rifampin, isoniazid, pyrazinamide, ethambutol
23 Recruiting T1 Mapping in HIV Patients With High and Low CD4+ Cell Counts
Conditions: Heart Diseases;   HIV
Intervention:
24 Recruiting HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium
Conditions: HIV;   COPD;   Emphysema;   Smoking
Intervention:
25 Completed Assessing the Impact of an Intervention to Prevent Intimate Partner Violence and HIV in Uganda
Conditions: HIV;   Physical Abuse of Adult (If Focus of Attention is on Victim);   Sexual Abuse of Adult (If Focus of Attention is on Victim);   Risk Reduction Behavior
Intervention: Behavioral: The SHARE Project
26 Recruiting Immunosuppressive Effects of Smoking and HIV-1 on the Development of Lung Disease
Conditions: HIV;   Smoking;   COPD
Intervention:
27 Active, not recruiting Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
Condition: Smallpox
Intervention: Biological: IMVAMUNE®
28 Completed Comparative Trial of Antidepressant Treatment Models in HIV Care in Uganda
Condition: Depression
Intervention: Drug: antidepressant therapy
29 Completed Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia
Condition: Measles
Intervention: Drug: Measles vaccine
30 Completed Evaluation of PTB Screening in ANC in Lusaka, Zambia
Condition: Pulmonary Tuberculosis
Interventions: Other: TB screening Questionnaire;   Other: Sputum smear and culture (only in HIV negative women who are symptomatic)
31 Recruiting Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa
Conditions: Hepatitis B Virus;   HIV;   Antiretroviral Therapy;   Africa;   Liver Fibrosis
Intervention: Other: Standard of care
32 Completed Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV
Condition: Tuberculosis
Intervention: Other: Comprehensive TB screening
33 Unknown  Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects
Conditions: Impaired Cognition;   Depression/Anxiety;   Poor Quality Sleep;   Quality of Life;   HIV-1 Infection
Interventions: Drug: Immediate switch to TDF/FTC/RPV;   Drug: Switch to TDF/FTC/RPV after 12 weeks
34 Active, not recruiting International Latino Research Partnership
Condition: Substance Use (Drugs, Alcohol)
Intervention: Behavioral: Integrated Intervention for Dual Problems and Early Action
35 Completed A Feasibility Study to Assess Tenofovir and Maraviroc Protection Against HIV-1 in Cervical and Vaginal Explants
Condition: Healthy Adult Females
Interventions: Drug: Tenofovir;   Drug: Maraviroc
36 Recruiting CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Conditions: Chronic Myeloid Leukemia (CML);   Acute Myelogenous Leukemia (AML);;   Myelodysplastic Syndrome (MDS);;   Juvenile Myelomonocytic Leukemia (JMML);;   Acute Lymphoblastic Leukemia (ALL);;   Lymphoma (Hodgkin's and Non-Hodgkin's)
Interventions: Device: CliniMACS CD34+ Reagent System;   Drug: Thiotepa;   Drug: Cyclophosphamide;   Drug: Alemtuzumab;   Drug: Tacrolimus;   Drug: Melphalan;   Drug: Busulfan;   Drug: Fludarabine;   Drug: Methylprednisolone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Study has passed its completion date and status has not been verified in more than two years.